The tech rally still has room to run. Thank you. See how that works. Intels chief Financial Officer bob wan is back with us, talk about the chip anchors better than the expected earnings and concerns at rival amd could be taking a bite out of its business. They had to defend themselves on the intel Conference Call. Some of the analysts asking about that tremendous competition from amd these days. Yeah. Well ask him about that so lets begin with amazon still weighing on the tech sector. Bertha coombs has more. Reporter following that earnings misamazon seeing its worst day since early june selling off on pretty strong volume and thats providing the biggest point drag on the nasdaq 100 but amazon is coming off an alltime high just yesterday and shares are still up fractionally for the week and in fact up 6 with one more trading day left here in the month of july. The impact on bigcap tech is somewhat muted the major tech indices are down fractionally and treating volume actually isnt ref
A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical.
/PRNewswire/ NPact, a leading provider of grant and donor management software, today announced it has signed an agreement with Blackbaud Inc. to acquire its.
Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University - read this article along with other careers information, tips and advice on BioSpace